Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted Capital Expenditures of $32,000 for Q2 2026, down 13.5% from $37,000 a year earlier but up 113.3% from the prior quarter.
Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Rani Therapeutics Holdings was $47,000, down 80.7% year-over-year; for FY2025, it came in at $88,000, down 67.2% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -40.7% (FY2020 to FY2025).
- In prior years, Rani Therapeutics Holdings' Capital Expenditures was $268,000 in FY2024 (-78.2%), $1.23 million in FY2023 (-24.1%), $1.62 million in FY2022 (+220.0%) and $506,000 in FY2021 (-57.8%).
- Quarterly Capital Expenditures has run from a low of $15,000 in Q1 2026 to a high of $530,000 in Q4 2022 over five years.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last six quarters, with an average decline of 19.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2025, with growth of 183.3%; the weakest was Q1 2024, with a decline of 92.7%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Rani Therapeutics Holdings | 109.55 Mn | -10.01 Mn | - | 32,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Sep 30, 2023 | 479,000.00 |
| Jun 30, 2023 | 335,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 530,000.00 |
| Sep 30, 2022 | 456,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 271,000.00 |
| Jun 30, 2021 | 136,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 256,000.00 |
Rani Therapeutics Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RANI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();